hydrocortisone / sulfacetamide

RxCUI
1007936
RxNorm name
hydrocortisone / sulfacetamide
Term type
MIN
Status
Active
Updated
2026-06-13 07:06:16

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
092010
Active start
092010
Multiple ingredient
YES
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
sulfacetamide10169
hydrocortisone5492

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
RXNAV_STRhydrocortisone / sulfacetamideNAMES
RxNorm Namehydrocortisone / sulfacetamideNAMES
TTYMINATTRIBUTES
RxCUI1007936CODES

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AFAntiinfectives for treatment of acneATC1-4sulfacetamide
ATCC05AACorticosteroidsATC1-4hydrocortisone
ATCS02BACorticosteroidsATC1-4hydrocortisone
ATCA07EACorticosteroids acting locallyATC1-4hydrocortisone
ATCA01ACCorticosteroids for local oral treatmentATC1-4hydrocortisone
ATCS01BACorticosteroids, plainATC1-4hydrocortisone
ATCD07AACorticosteroids, weak (group I)ATC1-4hydrocortisone
ATCD07XACorticosteroids, weak, other combinationsATC1-4hydrocortisone
ATCS01CBCorticosteroids/antiinfectives/mydriatics in combinationATC1-4hydrocortisone
ATCH02ABGlucocorticoidsATC1-4hydrocortisone
ATCS01ABSulfonamidesATC1-4sulfacetamide
FDASPLD013449SulfonamidesCHEMhas_chemical_structuresulfacetamide
FDASPLN0000175576CorticosteroidEPChas_epchydrocortisone
FDASPLN0000175503Sulfonamide AntibacterialEPChas_epcsulfacetamide
MEDRTD006854HydrocortisoneCHEMhas_ingredienthydrocortisone
MEDRTD013409SulfacetamideCHEMhas_ingredientsulfacetamide
MEDRTD000312Adrenal Hyperplasia, CongenitalDISEASEmay_treathydrocortisone
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treathydrocortisone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treathydrocortisone
MEDRTD003320Corneal UlcerDISEASEmay_treatsulfacetamide
MEDRTD003877Dermatitis, ContactDISEASEmay_treathydrocortisone
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsulfacetamide
MEDRTD003881DermatomycosesDISEASEci_withhydrocortisone
MEDRTD004342Drug HypersensitivityDISEASEci_withsulfacetamide
MEDRTD004342Drug HypersensitivityDISEASEci_withhydrocortisone
MEDRTD004427Ear DiseasesDISEASEmay_treatsulfacetamide
MEDRTD005148Facial DermatosesDISEASEmay_treathydrocortisone
MEDRTD005533Foot DermatosesDISEASEmay_treathydrocortisone
MEDRTD006229Hand DermatosesDISEASEmay_treathydrocortisone
MEDRTD006484HemorrhoidsDISEASEmay_treathydrocortisone
MEDRTD007231Infant, NewbornDISEASEci_withsulfacetamide
MEDRTD007249InflammationDISEASEmay_treathydrocortisone
MEDRTD007868Leg DermatosesDISEASEmay_treathydrocortisone
MEDRTD011538Pruritus AniDISEASEmay_treathydrocortisone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treathydrocortisone
MEDRTD012536Scalp DermatosesDISEASEmay_treathydrocortisone
MEDRTD012769ShockDISEASEmay_treathydrocortisone
MEDRTD017192Skin Diseases, BacterialDISEASEmay_treatsulfacetamide
MEDRTD012876Skin Diseases, ParasiticDISEASEci_withhydrocortisone
MEDRTD017193Skin Diseases, ViralDISEASEci_withhydrocortisone
MEDRTD013224Status AsthmaticusDISEASEmay_treathydrocortisone
MEDRTD014141TrachomaDISEASEmay_treatsulfacetamide
MEDRTD014382Tuberculosis, CutaneousDISEASEci_withhydrocortisone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moahydrocortisone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moahydrocortisone
MEDRTN0000009946Para-Aminobenzoic Acid InhibitorsMOAhas_moasulfacetamide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pehydrocortisone
MEDRTN0000008344Cellular Growth Phase ArrestPEhas_pesulfacetamide
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pesulfacetamide
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pehydrocortisone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pehydrocortisone
MEDRTN0000009935Decreased Folic Acid ModificationPEhas_pesulfacetamide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pehydrocortisone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pehydrocortisone
MEDRTN0000008700Decreased Lysosomal FunctionPEhas_pehydrocortisone
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pehydrocortisone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pehydrocortisone
MEDRTN0000008841Decreased Protein SynthesisPEhas_pehydrocortisone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pehydrocortisone
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pehydrocortisone

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESTTYMIN
CODESRxCUI1007936
NAMESRXNAV_STRhydrocortisone / sulfacetamide
NAMESRxNorm Namehydrocortisone / sulfacetamide